Digital Neuro Biomarkers Market Report 2026

Digital Neuro Biomarkers Market Overview

• Digital Neuro Biomarkers market size has reached to $0.95 billion in 2025 • Expected to grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 27.2% • Growth Driver: Surge In Focus On Early Detection And Monitoring Of Neurological Disorders Through Digital Tools Fueling Growth Of The Market Through Real-Time Data, Early Intervention, And Advanced Patient Care • Market Trend: Developing Open-Access Wearable Research Platforms To Advance Digital Neuro Biomarker Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Digital Neuro Biomarkers Market?

Digital neuro biomarkers refer to objective, quantifiable physiological and behavioral data collected using digital technologies, such as wearable devices, mobile applications, sensors, and artificial intelligence algorithms, to measure brain health, cognitive function, and neurological disease progression. These biomarkers enable early diagnosis, continuous monitoring, personalized treatment, and improved patient outcomes in neurological care. These biomarkers support clinical decision-making, facilitate remote monitoring, enhance research in neuroscience, and promote precision neurology. The main types of digital neuro biomarkers are including wearable devices, mobile-based applications, sensors, and other types. Wearable devices refer to technology-enabled instruments that continuously monitor and collect neurological and behavioral data from patients, enabling the assessment of cognitive, motor, speech, and behavioral functions. The deployed through cloud-based platforms, on-premise platforms, or hybrid deployment models. The capture biomarkers types such as cognitive digital biomarkers, motor function digital biomarkers, speech and language digital biomarkers, and behavioral digital biomarkers. The end users including healthcare companies, healthcare providers, payers, and others.

What Is The Digital Neuro Biomarkers Market Growth Forecast?

The digital neuro biomarkers market size is expected to see exponential growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 27.2%. The growth in the forecast period can be attributed to increasing integration of artificial intelligence in neurological diagnostics, growing demand for remote patient monitoring, expansion of tele-neurology services, rising investments in neuroscience research, and development of personalized neurology treatment solutions. Major trends in the forecast period include greater use of cloud-based neurological data analytics, adoption of real-time brain monitoring technologies, expansion of mobile cognitive assessment applications, integration of machine learning in biomarker analysis, and growth of predictive and precision neurology platforms.

Global Digital Neuro Biomarkers Market Segmentation

1) By Type: Wearable, Mobile-Based Applications, Sensors, Other Types 2) By Deployment Mode: Cloud-Based Platforms, On-Premise Platforms, Hybrid Deployment Models 3) By Biomarker Type: Cognitive Digital Biomarkers, Motor Function Digital Biomarkers, Speech And Language Digital Biomarkers, Behavioral Digital Biomarkers 4) By End-User: Healthcare Companies, Healthcare Providers, Payers, Other End-Users Subsegments: 1) By Wearable: Smart Wristbands, Smart Headbands, Smart Watches, Smart Clothing, Implantable Devices 2) By Mobile-Based Applications: Cognitive Assessment Applications, Neurological Monitoring Applications, Mental Health Tracking Applications, Motor Function Assessment Applications, Speech And Language Tracking Applications 3) By Sensors: Electroencephalography Sensors, Electrocardiography Sensors, Eye Tracking Sensors, Motion Tracking Sensors, Biometric Monitoring Sensors 4) By Other Types: Cloud Based Platforms, Data Analytics Tools, Digital Therapeutic Platforms, Artificial Intelligence Enabled Assessment Tools, Virtual Reality Based Assessment Tools

What Is The Driver Of The Digital Neuro Biomarkers Market?

The increasing focus on early detection and monitoring of neurological disorders is expected to propel the growth of the digital neuro biomarkers market. Early detection and monitoring involve the use of digital technologies such as wearable devices, mobile applications, and sensors to continuously assess neurological function, cognition, and behaviour, enabling timely identification of neurological conditions. This focus is intensifying due to public health initiatives and clinical priorities aimed at identifying cognitive impairment and neurodegenerative diseases before severe symptoms emerge. Digital neuro biomarkers support these efforts by delivering objective, real-time data that help clinicians and researchers detect subtle neurological changes and initiate early interventions. For instance, in 2024, according to the U.S. Centres for Disease Control and Prevention’s Healthy Brain Initiative highlights that neurological disorders affect approximately one billion people globally, including around 50 million individuals with epilepsy and 24 million with Alzheimer’s disease. Therefore, the increasing focus on early detection and monitoring of neurological disorders through digital tools is driving the growth of the digital neuro biomarkers industry.

Key Players In The Global Digital Neuro Biomarkers Market

Major companies operating in the digital neuro biomarkers market are F. Hoffmann-La Roche AG, Merck KGaA, Biogen Inc., Evidation Health Inc., Huma Therapeutics Limited, Altoida Inc, Cogstate Limited, Quibim S.L., Empatica Inc., Linus Health Inc., Cambridge Cognition Holdings plc, Brainomix Limited, Mindstrong Health Inc., Neurotrack Technologies Inc., Feel Therapeutics Inc., BrainCheck Inc., IXICO plc, NeuraMetrix Inc., NeuraLight Ltd., Koneksa Health Inc., Sonde Health Inc., Aural Analytics Inc., Winterlight Labs Inc.

Global Digital Neuro Biomarkers Market Trends and Insights

Major companies operating in the digital neuro biomarkers market are focusing on developing open-access research infrastructure, such as WearGait PD, to support the development, validation, and regulatory evaluation of wearable-based digital neuro biomarkers for neurological disorders. WearGait PD refers to a regulatory science dataset that provides synchronized wearable sensor and gait data from individuals with Parkinson’s disease and age-matched controls, enabling the extraction and evaluation of gait-derived digital biomarkers for disease monitoring and progression assessment. For instance, in July 2024, the U.S. Food and Drug Administration (FDA), a U.S.-based regulatory agency, published WearGait PD: Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls, an open-access dataset designed to support researchers and industry developers in deriving and validating digital biomarkers. The dataset includes raw inertial measurement unit (IMU) acceleration and rotational velocity data, insole pressure recordings, and synchronized gait annotations, facilitating algorithm testing, metric validation, and the development of wearable sensor-based monitoring tools.

What Are Latest Mergers And Acquisitions In The Digital Neuro Biomarkers Market?

In January 2023, Cambridge Cognition Holdings PLC, a UK based developer of digital cognitive assessment tools and brain health solutions, acquired Winterlight Labs Inc. for £7.0 million (approximately $8.6 million). With this acquisition, Cambridge Cognition aims to expand its digital neuro biomarker portfolio by integrating Winterlight’s proprietary free speech analysis technology, thereby enhancing the company’s ability to assess and monitor cognitive impairment in clinical research and drug development settings. Winterlight Labs Inc. is a Canada based provider of digital biomarkers focused on speech derived metrics for detecting and tracking cognitive function in neurological conditions.

Regional Insights

North America was the largest region in the digital neuro biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Neuro Biomarkers Market?

The digital neuro biomarkers market consists of revenues earned by entities through services and products such as wearable brain monitoring devices, mobile cognitive assessment applications, sensor-based data collection platforms, cloud-based neurological data analytics, and artificial intelligence-enabled diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital neuro biomarkers market also includes sales of software platforms, wearable devices, mobile applications, and sensor-based diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods and services sold by the creators of the goods, whether to other entities (including downstream manufacturers, healthcare providers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Neuro Biomarkers Market Report 2026?

The digital neuro biomarkers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital neuro biomarkers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.